CBV3

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,consum report with the FDA on 2018-05-30 for CBV3 manufactured by Actegy Ltd.

Event Text Entries

[109578043] Manufacturer's analysis: the device is not contraindicated for use in the presence of varicosities. The instructions for use (ifu) describes an adequate setting as when the individual can "feel the mild electrical impulses in your feet and the muscles in the calf visibly pulsing or twitching but at a level that is not uncomfortable". The device intensity range is 0-99 (0 being the lowest, and 99 being the highest intensity setting). The individual has stated that they used the device at an intensity of "9-12". We believe it is most likely that the user in this case, (b)(6), has not used the device as described in the ifu. The intensity has not been applied at a sufficiently high enough intensity to create the required muscle contraction. We expect that the device would have had little effect at this level of intensity, if at all. Therefore we believe the most likely cause of varicose veins in this (b)(6) lady, is the natural progression of her underlying medical condition. Case closed as patient underlying medical condition is not device related.
Patient Sequence No: 1, Text Type: N, H10


[109578044] Please note: following an fda inspection at actegy ltd between march 5-8, 2018 by mr. (b)(4) it was identified this incident should have been reported to fda. Therefore, the following incident is being reported retrospectively: following the purchase of the new device and use for 6 months (b)(6) reported that she has suffered from varicosities on both her legs and that her veins have gradually increased in size since the first and subsequent use of the device ((b)(6) 2017). According to (b)(6) the device was purchased to relieve a "tingling sensation" in her legs and was being used for 30 minutes every day on intensity levels between 9 and 12. On (b)(6) 2017 (b)(6) doctor provided a letter to actegy ltd advising that her patients varicose vein condition had occurred following the use of the device which had not existed prior to this. The doctor also advised that these symptoms would likely require specialist intervention (laser or local sclerosis) following the aesthetic concerns raised by her patient.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3010078417-2018-00005
MDR Report Key7553406
Report SourceCOMPANY REPRESENTATIVE,CONSUM
Date Received2018-05-30
Date of Report2018-05-30
Date of Event2017-08-21
Date Mfgr Received2017-08-21
Date Added to Maude2018-05-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. LAWRENCE BROOKFIELD
Manufacturer StreetREFLEX CAIN ROAD
Manufacturer CityBRACKNELL, BERKSHIRE RG121HL
Manufacturer CountryUK
Manufacturer PostalRG12 1HL
Manufacturer G1MIRA MEDI & TECH CO., LTD
Manufacturer Street22 BAEKSUK-DONG 5-GIL SEOBUK-GU
Manufacturer CityCHEONAN CITY,
Manufacturer CountryKS
Single Use3
Remedial ActionPM
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCBV3
Generic NameCIRCULATION BOOSTER
Product CodeNUH
Date Received2018-05-30
Model NumberCBV3
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Age3 YR
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerACTEGY LTD
Manufacturer AddressREFLEX CAIN ROAD BRACKNELL, BERKSHIRE RG121HL UK RG12 1HL


Patients

Patient NumberTreatmentOutcomeDate
10 2018-05-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.